Purpose: Improving hypertension management is still one of the biggest challenges in public health worldwide. Existing guidelines do not reach a consensus on the optimal Blood Pressure (BP) target. Therefore, how to effectively manage hypertension based on individual characteristics of patients, combined with the pharmacological and non-pharmacological approach, has become a problem to be urgently considered.
Methods: Reports published in PubMed that covered Pharmacological and Non-Pharmacological Approaches in subjects taking hypertension management were reviewed by the group independently and collectively. Practical recommendations for hypertension management were established by the panel.
Results: Pharmacological mechanism, action characteristics, and main adverse reactions varied across different pharmacological agents, and patients with hypertension often require a combination of antihypertensive medications to achieve the target BP range. Non-pharmacological treatment provides an additional effective method for improving therapy adherence and long-term BP control, thus reducing the risk of cardiovascular diseases, and slowing down the progression of the disease.
Conclusion: This review summarizes the available literature on the most convincing guideline principles, pharmacological treatment, biotechnology interference, interventional surgical treatment, managing hypertension with technical means of big data, Artificial Intelligence and Behavioral Intervention, as well as providing future directions, for facilitating Current and Developing knowledge into clinical implementation.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.115.018912] [PMID: 27502908]
[http://dx.doi.org/10.1016/S0140-6736(16)31679-8] [PMID: 27733284]
[http://dx.doi.org/10.1161/CIRCULATIONAHA.111.068064] [PMID: 22379110]
[http://dx.doi.org/10.1016/j.cct.2018.08.013] [PMID: 30172038]
[http://dx.doi.org/10.1161/CIR.0000000000000678] [PMID: 30879355]
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.11388] [PMID: 30354719]
[http://dx.doi.org/10.1093/ndt/gft369] [PMID: 24009293]
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.11434] [PMID: 29987102]
[http://dx.doi.org/10.1146/annurev-med-050416-024516] [PMID: 29414255]
[http://dx.doi.org/10.1016/j.clinthera.2016.07.008] [PMID: 27502326]
[http://dx.doi.org/10.1111/j.1365-2796.2011.02417.x] [PMID: 21682782]
[http://dx.doi.org/10.1161/CIRCHEARTFAILURE.119.006213] [PMID: 31525068]
[http://dx.doi.org/10.1111/j.1524-6175.2006.04482.x] [PMID: 15858399]
[http://dx.doi.org/10.1111/j.1524-6175.2006.05797.x] [PMID: 17086018]
[http://dx.doi.org/10.1016/S0140-6736(13)61914-5] [PMID: 24094767]
[http://dx.doi.org/10.1161/CIRCULATIONAHA.114.008723] [PMID: 26596977]
[http://dx.doi.org/10.1016/S0140-6736(18)32225-6] [PMID: 30496105]